Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin
Open Access
- 1 October 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (38) , 40970-40980
Abstract
Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectinKeywords
This publication has 52 references indexed in Scilit:
- Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironmentCancer and Metastasis Reviews, 2012
- Transient CPEB dimerization and translational controlRNA, 2012
- Glycosylation, galectins and cellular signalingCurrent Opinion in Cell Biology, 2011
- Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2 binding protein in human cellsMolecular Biology of the Cell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Low‐SDS Blue native PAGEProteomics, 2011
- Eicosanoids and cancerNature Reviews Cancer, 2010
- Galectin-8 Induces Apoptosis in Jurkat T Cells by Phosphatidic Acid-mediated ERK1/2 Activation Supported by Protein Kinase A Down-regulationJournal of Biological Chemistry, 2009
- Galectin–glycan lattices regulate cell-surface glycoprotein organization and signallingBiochemical Society Transactions, 2008
- Functions of cell surface galectin-glycoprotein latticesCurrent Opinion in Structural Biology, 2007